A cancer diagnosis often brings urgent questions about care and costs. Many people wonder whether Medicare will help cover the treatments their doctor recommends. The good news is that Medicare does provide substantial coverage for medically necessary cancer care.
Original Medicare, Medicare Advantage plans, and Part D prescription coverage each play a role depending on where and how treatment is delivered. Understanding these differences can help patients and families plan more confidently.
This guide explains what is covered, what patients typically pay, and how supplemental options can reduce out-of-pocket costs. Information is based on current Medicare rules and 2026 cost figures.
How Medicare Covers Cancer Care Across Its Parts
Medicare divides coverage by setting and type of service. Part A handles inpatient hospital care. Part B covers most outpatient services. Part D addresses many oral medications. Medicare Advantage plans must cover at least the same services as Original Medicare but may structure costs differently.
Part A covers cancer-related hospital stays, including inpatient surgery to remove tumors, inpatient chemotherapy, and radiation given during an admission. It also covers skilled nursing facility care after a qualifying hospital stay, certain home health services, and surgically implanted breast prostheses after mastectomy performed as an inpatient. Patients pay the Part A deductible of $1,736 per benefit period in 2026. For the first 60 days, no additional daily coinsurance applies after the deductible.
Part B covers the majority of outpatient cancer care. This includes chemotherapy given in a doctor’s office, clinic, or hospital outpatient department; radiation therapy; visits with oncologists and other specialists; diagnostic tests such as CT, PET, and MRI scans; lab work; and outpatient surgeries. Part B also covers some oral cancer drugs when an injectable form of the same drug exists. After the annual Part B deductible of $283 in 2026, patients generally pay 20 percent of the Medicare-approved amount.
Part D covers most oral cancer medications and other self-administered drugs that Part B does not cover. These include many targeted therapies and supportive medications such as anti-nausea drugs taken at home. Coverage depends on the specific plan’s formulary and tier placement. In 2026, once a patient’s out-of-pocket spending on covered Part D drugs reaches $2,100, they pay nothing further for those drugs for the rest of the calendar year.
Medicare Advantage plans (Part C) must cover everything Original Medicare covers. Many add benefits such as transportation to treatment or care coordination. These plans usually set copayments or coinsurance for services and include an annual out-of-pocket maximum that limits total spending on Part A and Part B services.
Does Medicare Cover Cancer Treatment Under Original Medicare and Advantage Plans
Original Medicare pays for medically necessary cancer treatments regardless of the patient’s age, as long as the person is enrolled and the provider accepts Medicare. Coverage applies to chemotherapy, radiation, surgery, immunotherapy, and targeted therapies when a doctor deems them necessary. Patients can see any provider who accepts Medicare assignment without network restrictions.
Medicare Advantage plans follow the same coverage rules for medically necessary care but often require patients to use in-network doctors and facilities. Prior authorization is more common under Advantage plans and can sometimes delay the start of treatment. Advantage plans provide an annual out-of-pocket maximum, which Original Medicare alone does not have.
Both Original Medicare and Advantage plans cover second opinions for surgery. If the first two surgical oncologists disagree, Medicare may also cover a third opinion. Preventive cancer screenings, such as mammograms, colonoscopies, and low-dose CT scans for lung cancer in eligible patients, are covered under Part B with no patient cost-sharing when criteria are met.
Coverage for Specific Cancer Treatments
Chemotherapy is covered whether given in the hospital or outpatient setting. Inpatient chemotherapy falls under Part A. Outpatient infusions or injections fall under Part B at 20 percent coinsurance after the deductible. Some oral chemotherapy drugs are covered under Part B if an injectable version exists; otherwise they typically fall under Part D.
Radiation therapy follows the same pattern. Outpatient radiation is covered by Part B at 20 percent after the deductible. Inpatient radiation is covered by Part A subject to the hospital deductible. Techniques such as external beam radiation, brachytherapy, and stereotactic radiosurgery are generally covered when medically necessary.
Surgery for cancer is covered under Part A when performed during an inpatient stay and under Part B when done on an outpatient basis. Related services such as anesthesia, pathology, and post-surgical care are included when the surgery itself is covered.
Immunotherapy and many targeted therapies given by infusion are covered under Part B. Oral versions usually fall under Part D. Coverage requires that the treatment be medically necessary and administered according to accepted standards.
Clinical trials for cancer may be covered under certain conditions. Medicare pays for routine costs associated with qualifying trials, though experimental drugs or devices themselves may not be covered.
What Patients Typically Pay
Costs vary by treatment setting and whether the patient has supplemental coverage. Under Original Medicare alone, the 20 percent Part B coinsurance has no annual limit. A lengthy course of chemotherapy or radiation can therefore lead to significant out-of-pocket expenses.
Medigap (Medicare Supplement) policies can cover the Part A deductible and the Part B 20 percent coinsurance. Plan G, for example, pays most of those costs after the Part B deductible is met. Medicare Advantage plans replace the 20 percent structure with plan-specific copays or coinsurance and impose an annual out-of-pocket maximum.
Part D costs depend on the drug’s tier and the plan’s design. The $2,100 annual out-of-pocket cap in 2026 provides important protection for expensive oral cancer medications. Some patients may also qualify for Extra Help, which further reduces drug costs.
| Treatment Type | Medicare Part | Typical Patient Share (2026, Original Medicare) |
|---|---|---|
| Inpatient surgery or chemo | Part A | $1,736 deductible per benefit period |
| Outpatient chemo or radiation | Part B | 20% after $283 deductible |
| Oral cancer drugs | Part D | Varies by plan; $0 after $2,100 OOP |
Gaps and Limitations in Coverage
Original Medicare does not cover wigs for hair loss caused by chemotherapy. Some Medicare Advantage plans may offer limited coverage or related benefits, so patients should check their specific plan. Cosmetic procedures and most experimental treatments outside approved clinical trials are not covered.
Observation status in a hospital can create confusion. A patient may stay overnight yet still be classified as an outpatient, meaning services fall under Part B rather than Part A. Asking hospital staff about inpatient versus outpatient status helps avoid unexpected bills.
Providers who do not accept Medicare assignment may charge more than the Medicare-approved amount. Patients generally pay the difference in addition to their usual share. Choosing providers who accept assignment helps control costs.
Tips for Managing Costs and Care
Patients should confirm coverage details with their oncologist’s office and their Medicare plan before starting treatment. Asking for an estimate of expected costs and whether prior authorization is required can prevent surprises.
Keeping records of all treatments, medications, and bills makes it easier to track spending toward deductibles and out-of-pocket limits. Patients with limited income may qualify for state Medicaid programs that work with Medicare or for charitable assistance from cancer organizations.
Reviewing plan options during the annual Medicare Open Enrollment Period allows patients to switch to a plan better suited to ongoing cancer care needs. Those with Original Medicare can also consider adding a Medigap policy if they are still in their open enrollment window for supplements.
Summary
Medicare covers a wide range of cancer treatments, including surgery, chemotherapy, radiation, immunotherapy, and many oral drugs. Coverage is split across Parts A, B, and D depending on the setting and how the treatment is given. Patients typically pay deductibles and 20 percent coinsurance under Original Medicare, though Medigap or Medicare Advantage plans can reduce those costs. Understanding the differences between plan types and confirming details with providers and the plan itself helps patients focus on recovery rather than unexpected bills.
FAQ
Does Medicare cover chemotherapy?
Yes. Part A covers chemotherapy given during a hospital inpatient stay. Part B covers outpatient chemotherapy in a doctor’s office, clinic, or hospital outpatient department. Patients pay the applicable deductible and usually 20 percent coinsurance under Part B after the deductible is met.
Does Medicare cover radiation therapy?
Yes. Outpatient radiation is covered under Part B at 20 percent of the Medicare-approved amount after the annual deductible. Radiation given during an inpatient hospital stay is covered under Part A subject to the hospital deductible for that benefit period.
Are oral cancer drugs covered by Medicare?
Most oral cancer drugs are covered under Part D prescription drug plans. Some oral drugs that have an injectable form available may be covered under Part B instead. Patients should check their specific Part D formulary for coverage and cost details.
Does Medicare Advantage cover the same cancer treatments?
Yes. Medicare Advantage plans must cover at least the same medically necessary cancer treatments as Original Medicare. Costs are structured differently, often with copays and an annual out-of-pocket maximum. Network rules and prior authorization requirements may apply.
What is not covered for cancer patients?
Original Medicare does not cover wigs for chemotherapy-related hair loss or most experimental treatments outside approved clinical trials. Cosmetic procedures unrelated to medical necessity are also excluded. Some supportive items may be available through certain Medicare Advantage plans.
